Co-Diagnostics, Inc. (CODX) › Shareholders' EquityCo-Diagnostics, Inc. (CODX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2015: -$1.15M2016: -$2.99M2017: $3.85M2018: -$1.06M2019: $1.74M2020: $66.70M2021: $134.48M2022: $114.52M2023: $85.58M2024: $53.88M2025: $20.63M$20.63M2015Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$20.63M-61.7%2024$53.88M-37.0%2023$85.58M-25.3%2022$114.52M-14.8%2021$134.48M+101.6%2020$66.70M+3739.2%2019$1.74M+264.1%2018-$1.06M-127.5%2017$3.85M+228.6%2016-$2.99M-161.0%2015-$1.15M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share